Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysisMichael Benatar, Iddo Magen, Caroline McHutchison et al.|EBioMedicine|2024Cited by 43
The potential of neurofilaments analysis using dry-blood and plasma spotsVittoria Lombardi, Andrea Malaspina|Scientific Reports|2020Cited by 28